ChemComm
Communication
Fig. 4 Confocal fluorescence images of A549/CDDP cells. The cells with
(A–C) or without (D–F) pre-incubation with NEM (50 mM) followed by
treatment with 2.5 mM TR-green for 20 min. Then the cellular TrxR were
stained with the TrxR1 (B-2) mouse antibody and Dylight 549-Goat
Anti-Mouse IgG (red). Images for TR-green (A, D) and IgG (red) (B, E) were
obtained using excitation at 405 and 547 nm, respectively. C, F are the
merged images from A/B and D/E respectively.
Fig. 3 (a) Time course fluorescence response of TR-green (1.0 mM) towards
TrxR (1.0 mM), Trx (1.0 mM), BSA (1.0 mM), GSH (1 mM), Cys (1 mM), and DTT
(1 mM). (b) The bars represent the initial slope (100 s) of the fluorescence
variation at 500 nm as a function of time (DF/Dt).
reactions between TR-green and different concentrations of TrxR,
Trx, GSH, Cys and DTT. As summarized in Table 1, the reaction
kinetics with TrxR was approximately 4748 times higher than with
GSH. Interestingly, Trx, which is regarded as a di-thiol molecule and
being much more active than DTT in redox reactions, shows a
reaction rate constant lower than that of TrxR by almost 40 times.
Accordingly, we demonstrated that TR-green exhibited no apparent
inhibitory activity toward Trx (Fig. S5, ESI†). These results further
evidenced the selectivity of TR-green toward TrxR.
To verify if the fluorescence enhancement was induced by the
Michael addition between TR-green and TrxR, TrxR was pre-treated
with iodoacetamide (IAM) to alkylate the free –SeH and –SH groups
first, and the kinetic curves were recorded. Fig. S2 (ESI†) shows that
pre-treatment with IAM could greatly decrease the fluorescence
intensity. Meanwhile, BSA could also turn on the fluorescence to a
much lower extent, and be decreased by the IAM treatment.
In order to further demonstrate that TR-green can be effective
under living cell conditions, the confocal imaging studies were con-
ducted. Basically, the cisplatin-resistant A549 (A549/CDDP) tumor
cells were chosen in this typical study mainly due to the elevated TrxR
level in this cell line.15 The cellular TrxR was stained with the TrxR1-
(B-2) mouse antibody and Dylight 549-Goat Anti-Mouse IgG (red).
Upon incubation with TR-green (2.5 mM) for 20 minutes, strong
fluorescence could be observed inside the cells (Fig. 4B). In contrast,
when the cells were pre-incubated with the –SeH/–SH alkylating agent
NEM (N-ethylmaleimide)16 for 30 minutes followed by treatment with
TR-green, the fluorescence intensity decreased obviously (Fig. 4E).
These results suggest that this probe works well in living cells.
In conclusion, we presented a simple and new covalent
fluorescent labelling probe for thioredoxin reductase based
on a Michael-type reaction strategy. With a high inhibitory
activity toward TrxR, the probe shows a fast response. By the
SDS-PAGE analysis, we found that TR-green covalently modified
TrxR at its C-terminal active site and emitted significant fluores-
cence. The in vitro kinetic analysis showed that the reaction rate
constant for TrxR is much higher than those for other tested
biological species and displayed good selectivity. The in vivo perfor-
mance of TR-green for TrxR was evidenced by confocal microscopy.
A TrxR inhibitor markedly decreased the intracellular fluorescence,
which further validated the covalent turn-on effect of TR-green.
Considering that TrxR has been evidenced to be overexpressed and
constitutively active in cancer cells, we expect that this probe could
be employed in further biological applications.
We acknowledge the Natural Science Foundation of China
(No. 30973619 and 81172931) and the National High-tech R&D
863 Program (No. 2008AA02Z304) for support for this work.
Notes and references
´
1 E. S. J. Arner and A. Holmgren, Eur. J. Biochem., 2000, 267, 6102–6109.
2 (a) P. Y. Gasdaska, M. M. Berggren, M. J. Berry and G. Powis, FEBS
Lett., 1999, 442, 105–111; (b) J. Lu, Cancer Res., 2006, 66, 4410–4418.
3 (a) K. Becker, C. Herold Mende, J. J. Park, G. Lowe and R. H. Schirmer,
J. Med. Chem., 2001, 44, 2784–2792; (b) M. Ueno, J. Biol. Chem., 1999,
274, 35809–35815.
4 (a) L. Zhang, D. Duan, Y. Liu, C. Ge, X. Cui, J. Sun and J. Fang, J. Am.
Chem. Soc., 2013, 136, 226–233; (b) M. H. Lee, J. H. Han, J. H. Lee, H. G.
Choi, C. Kang and J. S. Kim, J. Am. Chem. Soc., 2012, 134, 17314–17319.
5 S. Mizukami, Y. Hori and K. Kikuchi, Acc. Chem. Res., 2014, 47, 247–256.
6 (a) T. Sandalova, L. Zhong, Y. Lindqvist, A. Holmgren and G. Schneider,
Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 9533–9538; (b) L. Zhong, E. S. J.
Arner and A. Holmgren, Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 5854–5859.
7 (a) E. H. Chew, A. A. Nagle, Y. Zhang, S. Scarmagnani, P. Palaniappan,
T. D. Bradshaw, A. Holmgren and A. D. Westwell, Free Radicals Biol.
Med., 2010, 48, 98–111; (b) J. Fang and A. Holmgren, J. Am. Chem. Soc.,
2006, 128, 1879–1885.
Table 1 Rate constants for the reaction of TR-green with TrxR, Trx, GSH,
Cys and DTT
8 J. Fang, J. Biol. Chem., 2005, 280, 25284–25290.
Entry
ka
k/kGSH
9 (a) X. Qiu, Z. Liu, W. Y. Shao, X. Liu, D. P. Jing, Y. J. Yu, L. K. An,
S. L. Huang, X. Z. Bu, Z. S. Huang and L. Q. Gu, Bioorg. Med. Chem.,
2008, 16, 8035–8041; (b) B. Zhou, J. Huang, Y. Zuo, B. Li, Q. Guo,
B. Cui, W. Shao, J. Du and X. Bu, Eur. J. Pharmacol., 2013, 707, 130–139.
10 S. Ji, J. Yang, Q. Yang, S. Liu, M. Chen and J. Zhao, J. Org. Chem.,
2009, 74, 4855–4865.
TrxR
Trx
GSH
Cys
(1.32 Æ 0.22) Â 106
(3.26 Æ 0.32) Â 104
(2.78 Æ 0.33) Â 102
(3.38 Æ 0.38) Â 101
(4.29 Æ 0.40) Â 102
4748.02
117.27
1.00
0.12
1.54
DTT
11 (a) H. S. Jung, J. H. Han, T. Pradhan, S. Kim, S. W. Lee, J. L. Sessler,
T. W. Kim, C. Kang and J. S. Kim, Biomaterials, 2012, 33, 945–953;
a
The rate constants are expressed as (M s)À1
.
This journal is ©The Royal Society of Chemistry 2014
Chem. Commun., 2014, 50, 6987--6990 | 6989